FRBC_STRR3
ID FRBC_STRR3 Reviewed; 373 AA.
AC Q0ZQ46;
DT 25-APR-2018, integrated into UniProtKB/Swiss-Prot.
DT 22-AUG-2006, sequence version 1.
DT 03-AUG-2022, entry version 59.
DE RecName: Full=2-phosphonomethylmalate synthase {ECO:0000303|PubMed:18721747};
DE EC=2.3.3.19 {ECO:0000269|PubMed:18721747};
GN Name=frbC {ECO:0000303|PubMed:18721747};
GN ORFNames=VM95_23205 {ECO:0000312|EMBL:KJS60087.1};
OS Streptomyces rubellomurinus (strain ATCC 31215).
OC Bacteria; Actinobacteria; Streptomycetales; Streptomycetaceae;
OC Streptomyces.
OX NCBI_TaxID=359131;
RN [1]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, CATALYTIC ACTIVITY, AND
RP PATHWAY.
RC STRAIN=ATCC 31215 {ECO:0000312|EMBL:ABB90392.1};
RX PubMed=18721747; DOI=10.1016/j.chembiol.2008.07.010;
RA Eliot A.C., Griffin B.M., Thomas P.M., Johannes T.W., Kelleher N.L.,
RA Zhao H., Metcalf W.W.;
RT "Cloning, expression, and biochemical characterization of Streptomyces
RT rubellomurinus genes required for biosynthesis of antimalarial compound
RT FR900098.";
RL Chem. Biol. 15:765-770(2008).
RN [2]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC STRAIN=ATCC 31215 {ECO:0000312|EMBL:KJS60087.1,
RC ECO:0000312|Proteomes:UP000033699};
RA Ju K.-S., Doroghazi J.R., Metcalf W.;
RL Submitted (FEB-2015) to the EMBL/GenBank/DDBJ databases.
CC -!- FUNCTION: Involved in the biosynthesis of the phosphonic acid
CC antibiotic FR900098, a potential anti-malarial drug, which acts as a
CC potent inhibitor of 1-deoxy-D-xylulose 5-phosphate reductoisomerase
CC (DXR), the first enzyme in the nonmevalonate pathway for isoprenoid
CC biosynthesis. Catalyzes the condensation between acetyl-CoA and
CC phosphonopyruvate to yield (R)-2-(phosphonomethyl)malate.
CC {ECO:0000269|PubMed:18721747}.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=3-phosphonopyruvate + acetyl-CoA + H2O = (R)-2-
CC (phosphonomethyl)malate + CoA + H(+); Xref=Rhea:RHEA:52144,
CC ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:57287,
CC ChEBI:CHEBI:57288, ChEBI:CHEBI:71402, ChEBI:CHEBI:136541;
CC EC=2.3.3.19; Evidence={ECO:0000269|PubMed:18721747};
CC -!- PATHWAY: Antibiotic biosynthesis. {ECO:0000269|PubMed:18721747}.
CC -!- SIMILARITY: Belongs to the alpha-IPM synthase/homocitrate synthase
CC family. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; DQ267750; ABB90392.1; -; Genomic_DNA.
DR EMBL; JZKH01000051; KJS60087.1; -; Genomic_DNA.
DR RefSeq; WP_045699990.1; NZ_JZKH01000051.1.
DR AlphaFoldDB; Q0ZQ46; -.
DR SMR; Q0ZQ46; -.
DR EnsemblBacteria; KJS60087; KJS60087; VM95_23205.
DR KEGG; ag:ABB90392; -.
DR PATRIC; fig|359131.3.peg.5648; -.
DR OMA; SNMFAHE; -.
DR BioCyc; MetaCyc:MON-18399; -.
DR BRENDA; 2.3.3.19; 15041.
DR Proteomes; UP000033699; Unassembled WGS sequence.
DR GO; GO:0046912; F:acyltransferase activity, acyl groups converted into alkyl on transfer; IEA:InterPro.
DR GO; GO:0017000; P:antibiotic biosynthetic process; IEA:UniProtKB-KW.
DR GO; GO:0019752; P:carboxylic acid metabolic process; IEA:InterPro.
DR GO; GO:1901566; P:organonitrogen compound biosynthetic process; IEA:UniProt.
DR CDD; cd07939; DRE_TIM_NifV; 1.
DR Gene3D; 3.20.20.70; -; 1.
DR InterPro; IPR002034; AIPM/Hcit_synth_CS.
DR InterPro; IPR013785; Aldolase_TIM.
DR InterPro; IPR013477; NifV/FrbC.
DR InterPro; IPR000891; PYR_CT.
DR Pfam; PF00682; HMGL-like; 1.
DR PROSITE; PS00815; AIPM_HOMOCIT_SYNTH_1; 1.
DR PROSITE; PS00816; AIPM_HOMOCIT_SYNTH_2; 1.
DR PROSITE; PS50991; PYR_CT; 1.
PE 1: Evidence at protein level;
KW Antibiotic biosynthesis; Reference proteome; Transferase.
FT CHAIN 1..373
FT /note="2-phosphonomethylmalate synthase"
FT /id="PRO_0000443947"
FT DOMAIN 5..256
FT /note="Pyruvate carboxyltransferase"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01151"
SQ SEQUENCE 373 AA; 40381 MW; C273D081908C1BFB CRC64;
MRNDLVLEDT TLRDGEQTPG VAFSKETKTA ILNALIEAGV TSIEIGIPAM GGEELDFIKS
VVDRQDEARL VVWHRGVRED VERSLDLGFT SVHVGLPTSA GHLKASVRKD RTWLLATARD
MVKMAKDRGA FVSISAEDIA RTEISFLQEY AGVVAEAGAD RLRLSDTVGL LGPEAYGERV
AAVLSAADID VQCHAHNDFG LATANTLAGL KAGARYFHVT VNAIGERAGM ADLAQVVVAL
KKLYDRDLGI DLTKLKKVSR LVAEAAGHQV LPWQPITGDN VFAHESGIHA NGMFRDTSSF
EPFPPEHVGG ERRYVLGKHS GRALVAWALE QEGITPREEL LPHCLEEVRA LSIRIGGAVS
HEQLVEIYNK AAA